Citalopram and cardiac toxicity.

Citalopram and cardiac toxicity.

Item
http://www.wikidata.org/entity/Q38045165
Cardiovascular considerations in antidepressant therapy: an evidence-based reviewCitalopram Overdose: a Fatal Case.Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.The effect of MElatonin on Depressive symptoms, Anxiety, CIrcadian and Sleep disturbances in patients after acute coronary syndrome (MEDACIS): study protocol for a randomized controlled trial.Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients.Psychotherapeutic Agents in End-Stage Renal Disease.Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.Citalopram-Induced Long QT Syndrome and the Mammalian Dive Reflex.The Effects of the Adenosine Receptor Antagonists on the Reverse of Cardiovascular Toxic Effects Induced by Citalopram In-Vivo Rat Model of PoisoningThe Evergreening of Biopharmaceuticals: Time to Defoliate.Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study.
P2860

Citalopram and cardiac toxicity.

Item
http://www.wikidata.org/entity/Q38045165
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Citalopram and cardiac toxicity.
@en
type
label
Citalopram and cardiac toxicity.
@en
prefLabel
Citalopram and cardiac toxicity.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P356
P1433
P1476
Citalopram and cardiac toxicity.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698